Prometryne is a methylthio-s-triazine herbicide. Signifi cant trace amounts are found in the environment, mainly in water, soil, and food plants. The aim of this study was to establish brain and blood prometryne levels after single oral dose (1 g kg -1 ) in adult male and female mice. Prometryne was measured using the GC/MS assay at 1, 2, 4, 8, and 24 h after prometryne administration. Peak brain and blood prometryne values were observed 1 h after administration and they decreased in a time-dependent manner. Male mice had consistently higher brain and blood prometryne levels than female mice. The observed prometryne kinetics was similar to that reported for the structurally related herbicide atrazine.
Prometryne (N,N'-bis(1-methylethyl)-6-(methylthio)-1,3,5-triazine-2,4-diamine) is used to control annual broadleaf and grass weeds in corn, carrots, parsley, peanuts, cotton, pigeon peas, alfalfa, and many other cultivated plants (1) (2) (3) (4) . Its use has been associated with increased levels in soil, water, and air, and a risk to the environment and human health (5) . Prometryne is relatively persistent in water (6) (7) (8) and soil (9, 10) . It can also be found in ambient air near production or application sites (11) . Signifi cant traces were documented in plants consumed by humans and domestic animals (9, (12) (13) (14) and medicinal plants treated with this herbicide (15) . Trace levels of prometryne have also been reported in cow and human milk (16, 17) . Only minimal information on the toxicokinetics of triazine herbicides in mammals has been published and the knowledge about prometryne kinetics in various organs is restricted to rats (18, 19) . Little is known about prometryne presence in the central nervous system (CNS), but the partition coeffi cient log K ow =3.5 (2) and the polarity of prometryne suggest that it might enter the CNS. The objective of this study was to see the kinetics of a single oral dose (1 g kg -1 ) of prometryne in the brain and blood of CBA mice and to compare it with previously reported kinetics of the structurally related and widely used herbicide atrazine. We also wanted to see if there were any sex-related differences in prometryne kinetics.
MATERIALS AND METHODS

Animals
For the experiment we used inbred CBA mice of both sexes [(65±3) days old; male=(23.37±1.99) g; female=(22.25±1.14) g] from a mouse colony of the Zagreb University Faculty of Science. The animals were fed on a pellet diet (Pliva, Zagreb, Croatia) and had free access to tap water. Light and dark exchanged every 12 hours. The experiment observed the Croatian animal welfare regulations (20) and the Guide for the Care and Use of Laboratory Animals (21) .
Treatment of experimental animals with prometryne
The mice were randomly distributed to five experimental groups of 12 animals each, six male and six female, that received a single prometryne (C 10 -1 body mass in a 0.2 mL corn oil suspension. The control group was randomly selected from among sibling littermates and treated with the same volume of corn oil without prometryne. The control group also served to verify that the animals had not been exposed to prometryne through food or water.
The selected prometryne dose was the closest to the 1/3 of mice LD 50 of 3.75 g kg -1 that did not show lethal toxicity (LD 10 ) over 48 consecutive hours after administration, as established by pilot tests reported by EPA (1). Dosing was based previous toxicokinetic studies ( [22] [23] [24] [25] [26] that used doses higher than normally environmentally available to ensure detectable residue levels for our purposes.
Mice were weighed before oral administration of prometryne. Corn oil suspension with prometryne was given in the volume of 0.2 mL per animal with small adjustments to individual body mass to keep the same dose of prometryne per kilogram of body mass.
The mice were monitored for any visible clinical or behavioural signs of poisoning. They were killed by cervical dislocation one, two, four, eight, and 24 hours after prometryne administration.
The whole experiment was repeated three times.
Collection of blood and brains
Blood was collected from the heart according to the standard protocol (27) . Samples of whole blood were immediately frozen (-80 °C) until further use, which followed within three days.
After blood collection, animals were perfused with PBS to make sure that the brain prometryne referred to brain parenchyma only. Dissected brains were placed on ice pads, weighed and immediately homogenised with constant cooling. To collect brain and blood samples we used new and thoroughly cleaned sets of instruments for each mouse to avoid any contamination with traces of prometryne from other animals.
Brain and blood prometryne extraction and the GC/MS assay
Blood and brain prometryne was analysed using the standard GC/MS assay as described earlier (22, 28) . Briefl y, to extract prometryne from blood and brain, we mixed 0.2 mL of water atrazine solution (3.5 μg mL -1 ) as internal standard and 0.15 g of sodium wolframate (Na 2 WO 4 , Kemika, Zagreb, Croatia) with 0.5 mL of homogenised sample. After the salt was diluted, we added 2 mL of ethyl acetate/dichloromethane mixture (1:3; Sigma-Aldrich, Taufkirchen, Germany). After 5 min of vortexing and 10 min of centrifugation (6000 rpm), 1 mL of supernatant was transferred and desiccated. After desiccation, 0.1 mL of n-hexane (Sigma-Aldrich) was added to the sample for injection into a chromatograph Shimadzu GCMS-QP2010S with a5970 MSD model. We used a HP-5ms GC column (30 m, 0.25 mm i.d.; J&W Agilent Technologies, USA). The injection temperature was 275 °C , with an oven temperature of 90 °C increased to 280 °C in 11 min. A blank sample of blood and brains from control animals was measured in parallel to make sure that the animals were not exposed to prometryne or atrazine (used as an internal standard) through food or water. To establish the calibration curve, we used 20 known concentrations of prometryne and atrazine (range: 4 ng mL -1 to 2000 ng mL -1 ) which were added to the brain and blood samples collected from control mice. Each time before measurement, we added 0.2 mL of internal standard for every 0.5 mL of real samples from animals that received prometryne, and recovery was 80 % to 85 %. No traces of metabolites were seen.
Statistical analysis
For statistical analyses we used Statistica 5.0 software (StatSoft, Tulsa, USA). We analysed group means (± standard deviation of the mean) and made multiple comparisons between groups and sexes with ANOVA. For post-hoc analysis of differences between groups we employed Scheffé's and Duncan's test. We also determined the correlation and regression coeffi cients between brain and blood concentrations. The level of statistical signifi cance was set at P≤0.01 and P≤0.05. Tables 1 and 2 show blood and brain prometryne contents, respectively. The fi rst two rows in both tables bring separate results by the sexes and the third row combines these results. Table 3 is structured like the fi rst two tables and shows correlation and regression coefficients. Figures 1 and 2 show brain-blood correlations in either sex, and Figure 3 combines them.
RESULTS
Blood prometryne concentration
Prometryne (in ng mL -1 ) was detected in all blood samples collected over 24 hours from administration ( Table 1 ). During that time blood concentration declined steadily. One hour after dosing, blood prometryne signifi cantly differed (P≤0.01) between male and female mice, as males had almost double (1.6 fold) the prometryne concentration in females. Two hours after prometryne administration, females had 1.5 times lower blood prometryne than males, but the difference was not signifi cant. Viewed combined (m+f), prometryne concentration dropped 2.3 times from hour one to hour two post dosing (P≤0.01).
Four hours after administration, blood prometryne dropped further still (1.9 times in respect to hour two, P≤0.01 and 4.4 times in respect to hour one, P≤0.01). Again, the difference between males and females was significant (1.5 times lower in female mice, P≤0.01). On hours eight and 24 blood prometryne rapidly dropped in all treated animals; it dropped 4.4 times between hour four and eight and 4.7 times between hours 8 and 24. The difference between the sexes was still signifi cant (P≤0.01, 1.8 times lower in female mice).
Prometryne in brain
Prometryne (in ng mg -1 ) was detected in the brains of mice at all time points over the 24 hours after administration (Table 2 ). Brain prometryne mass fractions steadily declined throughout the experiment. On post-dose hour one, it was 1.5 times higher in male than in female mice (P≤0.01), which is similar to blood concentration differences between the sexes. On hour two post dose (m+f), the mass fraction dropped 3.5 times (P≤0.01). Female mice now had 1.3 times lower prometryne brain mass fraction than male mice, but the difference was not signifi cant. Again even though female mice had 1.3 times lower brain prometryne, the 
Figure 2 The relationship between brain and blood prometryne levels of prometryne measured at different time points after administration of a single dose in female CBA mice
Brain prometryne mass fraction / ng mg Table 3 and Figures 1-3 show the correlation between blood and brain prometryne levels and regression coeffi cients. The highest signifi cant positive correlation between brain and blood prometryne was determined in samples analysed one hour after administration. Two hours after administration, the correlation was still signifi cant and positive in females, but not in males. When analysed together, however, the correlation was positive and almost signifi cant (P=0.0508). The same was observed for samples collected four hours post dose. Again, the correlation was positive in both sexes, but signifi cant (P≤0.05) only in female mice. The correlation for combined data was positive and signifi cant (P≤0.05), although lower than on hour two. On hours eight and 24 post dose the correlation between brain and blood prometryne levels was no longer signifi cant in any group.
Correlation and regression analysis
DISCUSSION
This study was designed to simulate a normal oral exposure to prometryne from the environment (29) as previously shown by Maynard et al. (22) in rats. One of the goals was to compare the allometric differences (30) (31) (32) between rats used in the study of Maynard et al. (22) and mice which we regularly used in earlier prometryne toxicity studies (33, 34) . One of the key documents that directed the experiment was the OECD 407 guideline for 28-day subchronic toxicity studies in rodents (21) . According to this guideline, it is safe to give tested chemicals at intervals of every 24 h to avoid overdosing or bioaccumulation. However, Maynard et al. (22) established prometryne presence in rats even after 48 h. While no such fi ndings have been available for mice our results suggest that even though OECD 407 guideline recommends 24-h intervals for test chemicals, this recommendation should be taken with caution. After 24 h, prometryne was not completely eliminated from the blood of mice (Table 1) , which suggests that the remaining prometryne concentrations, however low, might build up with subchronic dosing and raise the bioavailable concentration (29) .
Although prometryne was present in the blood of exposed animals, its percentage in respect to the (22) found that 1.2 % to 1.9 % of the original oral dose of prometryne was absorbed and distributed in the blood of rats. All this suggests that blood absorption of orally administered prometryne is relatively low, at least in laboratory rodents. Data about prometryne toxicokinetics in the CNS of mammals are scarce, and our study gives an elementary view of prometryne's potential fraction and retention in the brain of mice (Table 2) . Prometryne in mice brain was in even lower levels than in blood (Table 2) . We selected the brain as the study organ for prometryne toxicokinetics (35) because it is well protected against xenobiotics and the hardest of organs to penetrate (36) (37) (38) .
Prometryne's unpolar molecular structure and its octanol/water partition coeffi cient make prometryne likely to reach the brain, because brain structures are rich in lipids and have a tendency to uptake or concentrate lipofi lic substances (37, 39) . Having in mind that prometryne has low blood absorption and yet it has been traced in so distant a compartment as the brain over 24 h, then this means that prometryne has a potential to pass through all compartments of the mammalian organism, including placenta and put embryo at risk.
To the best of our knowledge, our study is the fi rst to show the potential of prometryne to enter mouse brain, and it is the fi rst to analyse prometryne absorption, bioaccumulation, and elimination in neural tissue over a short time. The only records available in literature refer to the neurotoxic kinetics of atrazine, a pesticide structurally similar to prometryne (23, 24, 26) . Due to similar structure, the two compounds may share some toxicological properties (33, 34) . Our results confi rm this assumption, as they correspond to the fi ndings of Stoker and Cooper (40) , who examined the toxicokinetics of atrazine in rat brain and other organs. Similar to our results for prometryne, about 0.003 % of the administered dose of atrazine was found in the brain (40) .
Atrazine seems to directly affect the neuroendrocrine function (40, 41) . As our results confi rm the affi nity of prometryne for neural tissue, similar effects on the neuroendocrine functions are possible, but they have to be verifi ed in future studies.
Brain and blood prometryne levels in our study decreased over 24 h (Tables 1, 2 , and 3) and correlated well, but not over the full range of data. This fi nding is expected, given the rapid distribution and/or elimination in the fi rst two hours. Slower elimination is expected from hours 2 to 8, with elimination halftime (t 1/2 ) of approximately 2 h, and even slower terminal elimination with a half life of about 8 h. Similar decline was demonstrated for atrazine in rats (23) . It could be concluded that most of prometryne absorption in mouse blood occurs within the fi rst hour, followed by a rapid decline in concentration. This drop in the prometryne level is highly correlated between the brain and blood (Table 3 and Figure 1 ). The decrease rate from hour one to hour two is higher in the brain (Δc m+f =3.45x h ). This points to an active process of rapid prometryne elimination from the brain, since the prometryne has to move from brain against the higher concentration in blood (36, 44, 45) . In our study, we also observed sex-related differences in brain and blood prometryne kinetics. Blood prometryne was signifi cantly higher in male than in female mice at all measured times, save for hour two when it was higher, but not signifi cantly. Brain prometryne levels were similar between males and females, except on hour one measurement when males had a signifi cantly higher prometryne mass fraction. The differences between the sexes are particularly clear if one looks at medians (Tables 1 and 2 ). Higher prometryne levels (especially the peak values of the hour one) in males suggest higher absorption than in females. We also observed a different dynamic of change between the sexes. In both brain and blood, males had 1.5 times higher values on hour one. In the brain this difference was dropping towards hour 24 (1.1 times), while in blood it rose (1.76 times on hour 24). This might be explained by different body mass between the sexes [male=(23.37±1.99) g; female=(22.25±1.14) g] or by different fat and muscle ratio. Another explanation might be that active brain elimination occurs at the same rate regardless of the sex, while elimination mechanisms (detoxifi cation enzymes) in blood may slightly differ between males and females (see the correlation curves in Figures 2 and 3) . Therefore, neurotoxicity studies of prometryne with mice as a model organism should take into account sex differences in prometryne brain bioavailability.
Log-normal plots reveal a possible three-step elimination that could be modelled with classical pharmacokinetic models, which could greatly help researchers in designing prometryne neurotoxicity experiments. In our study, the correlation between brain and blood prometryne was stronger in female mice. Regression coeffi cients show slower prometryne elimination rate in male mice than in female. Regression analysis (as in Figures 1, 2, and 3 ) makes it possible to calculate time-course changes in blood and brain prometryne levels.
Sažetak
TOKSIKOKINETIKA PROMETRINA U MOZGU MIŠEVA Prometrin je metiltio-s-triazinski herbicid. Značajne količine prometrina zaostaju u tragovima u okolišu, poglavito u vodi, tlu i biljkama koje rabimo za prehranu. Cilj je rada izmjeriti količinu prometrina koja se apsorbira u mozgu i krvi nakon primijenjene akutne oralne doze (1 g kg -1 tjelesne mase) u odraslih miševa obaju spolova. Razine prometrina u mozgu i krvi izmjerene su GC/MS-om tijekom 1., 2., 4., 8. i 24. sata nakon izlaganja. Utvrđeno je da je udio prometrina koji se zadržava u živčanom tkivu relativno nizak ali detektabilan u odnosu na koncentraciju u krvi i koncentraciju primijenjene doze. Najviše koncentracije u krvi i maseni udjeli u mozgu zabilježeni su tijekom 1. sata nakon izlaganja, a s vremenom izmjerene vrijednosti značajno opadaju. Uočena je značajna razlika između mužjaka i ženki pri čemu mužjaci imaju značajno više razine prometrina u mozgu i krvi nego ženke. Opisana toksikokinetika prometrina pokazuje sličnosti s otprije opisanom i poznatom toksikokinetikom strukturalno sličnog herbicida atrazina. 
